These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36607399)

  • 21. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.
    Dubinsky MC; Dotan I; Rubin DT; Bernauer M; Patel D; Cheung R; Modesto I; Latymer M; Keefer L
    Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):985-997. PubMed ID: 34130572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease.
    Spina A; Mazzarella C; Dallio M; Romeo M; Pellegrino R; Durante T; Romano M; Loguercio C; Di Mauro M; Federico A; Gravina AG
    Rev Recent Clin Trials; 2022; 17(2):109-119. PubMed ID: 35346015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
    Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway.
    Opheim R; Moum KM; Småstuen MC; Moum B
    Qual Life Res; 2023 Mar; 32(3):691-699. PubMed ID: 36125603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding telehealth options during the COVID pandemic eliminated racial and age disparities in electronic communication by inflammatory bowel disease patients.
    Hayrapetian L; Zepp M; Rao S; Hennessey M; Houle M; Atienza M; Belfaqeeh OA; Dharia I; Khan A; Borum ML
    J Natl Med Assoc; 2021 Aug; 113(4):474-477. PubMed ID: 33941370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Parekh R; Zhang X; Ungaro RC; Brenner EJ; Agrawal M; Colombel JF; Kappelman MD
    Dig Dis Sci; 2022 Apr; 67(4):1271-1277. PubMed ID: 34181165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The COVID-19 Pandemic Significantly Impacts Pregnancy Planning and Mental Health of Women With Inflammatory Bowel Disease.
    Tandon P; O'Connor K; Nguyen G; Maxwell C; Huang V
    J Clin Gastroenterol; 2023 Feb; 57(2):178-184. PubMed ID: 35081079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.
    Richter V; Bermont A; Cohen DL; Broide E; Shirin H
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):267-273. PubMed ID: 34191758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.
    De Nicolò A; Cusato J; Bezzio C; Saibeni S; Vernero M; Disabato M; Caviglia GP; Ianniello A; Manca A; D'Avolio A; Ribaldone DG
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Questionnaire-Based Study of 81 Patients in Poland to Evaluate the Course of Inflammatory Bowel Disease and the Effects of the COVID-19 Pandemic on Quality of Life and Mental State from February to June 2021.
    Owsianko N; Romańczuk-Osenka N; Szczerbakow M; Pikora K; Sowa K; Daniluk U; Rogalski P; Świdnicka-Siergiejko A; Antonowicz S; Krzyżak M; Maślach D; Dąbrowski A; Daniluk J
    Med Sci Monit; 2022 Nov; 28():e938243. PubMed ID: 36316965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results.
    Fernández Álvarez P; Belvis Jiménez M; Maldonado Pérez B; Castro Laria L; Caunedo Álvarez Á; Rodríguez de Los Ríos JL; Argüelles-Arias F
    Rev Esp Enferm Dig; 2021 Feb; 113(2):92-97. PubMed ID: 33371692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
    Taft TH; Quinton S; Jedel S; Simons M; Mutlu EA; Hanauer SB
    Inflamm Bowel Dis; 2022 May; 28(5):710-719. PubMed ID: 34137449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic.
    Wang H; Tu L; Li Y; Bai T; Zou K; Xiao F; Li J; Chen M; Zhang H; Li G; Lu Y; Wang K; Jin S; Yang Y; Zhu L; Hou X
    J Immunol Res; 2020; 2020():2847316. PubMed ID: 33062719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.
    Deputy M; Sahnan K; Worley G; Patel K; Balinskaite V; Bottle A; Aylin P; Burns EM; Hart A; Faiz O
    Aliment Pharmacol Ther; 2022 Apr; 55(7):836-846. PubMed ID: 35132663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.